211 - 220 of 6310 Results
Title
Year
- Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in Children2022OPENTitle: Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in ChildrenJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1526End Page: 1531Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29027Best OA location URL: https://doi.org/10.1002/mds.29027Citation Count: 17
-
OPENTitle: Pimavanserin Treatment for Parkinson’s Disease Psychosis in Clinical PracticeJournal Name: Parkinson's DiseasePublisher: WileyVol: 2021Issue #:Start Page: 1End Page: 10Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2021/2603641Best OA location URL: https://downloads.hindawi.com/journals/pd/2021/2603641.pdfCitation Count: 12
-
OPENTitle: Characterizing Advanced Parkinson’s Disease: Romanian Subanalysis from the OBSERVE-PD StudyJournal Name: Parkinson's DiseasePublisher: WileyVol: 2021Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2021/6635618Best OA location URL: https://downloads.hindawi.com/journals/pd/2021/6635618.pdfCitation Count: 18
-
OPENTitle: Continuous Subcutaneous Levodopa Delivery for Parkinson’s Disease: A Randomized StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 1Start Page: 177End Page: 186Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202285Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202285?id=journal-of-parkinsons-disease%2Fjpd202285Citation Count: 49
-
OPENTitle: Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1079End Page: 1089Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212594Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212594?id=journal-of-parkinsons-disease%2Fjpd212594Citation Count: 50
-
OPENTitle: Safety and Tolerability of Burst-Cycling Deep Brain Stimulation for Freezing of Gait in Parkinson’s DiseaseJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2021.651168Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2021.651168/pdfCitation Count: 10
-
OPENTitle: The Parkinson’s Real-World Impact Assessment (PRISM) Study: A European Survey of the Burden of Parkinson’s Disease in Patients and their CarersJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1309End Page: 1323Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-212611Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212611?id=journal-of-parkinsons-disease%2Fjpd212611Citation Count: 15
-
OPENTitle: Association of specific biotypes in patients with Parkinson disease and disease progressionJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 95Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000010498Best OA location URL: https://n.neurology.org/content/neurology/95/11/e1445.full.pdfCitation Count: 34
-
OPENTitle: Clinical and pathologic features of cognitive-predominant corticobasal degenerationJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 95Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000009734Best OA location URL: https://n.neurology.org/content/neurology/95/1/e35.full.pdfCitation Count: 17
- Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion2020OPENTitle: Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusionJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 7Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000000711Best OA location URL: https://nn.neurology.org/content/nnn/7/3/e711.full.pdfCitation Count: 11